Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Dong-A Pharmaceutical Co., Ltd. clinical trials
Part of Dong-A Socio Holdings Co., Ltd., which holds 100% as of 2025-12-31. Source
The registry lists 22 studies whose lead sponsor is Dong-A Pharmaceutical Co., Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 9, 2026.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Dong-A Pharmaceutical Co., Ltd..
- Dong-A Pharmaceutical Co., Ltd.19 studiesSame company
Something wrong?
- Dong-A Pharmaceutical3 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 22 of 22.
- Evaluate the Efficacy and Safety of Hydrolyzed Keratin Peptide Powder on Hair HealthCompletedNCT07458828Not applicable
Sponsor listed in the registry: Dong-A Pharmaceutical
- Effect of DA-5515 (Circulan® Soft Cap.) in Patients With Chronic Fatigue Symptoms Due to Impaired Blood CirculationStatus unknownNCT03542721Phase 4
Sponsor listed in the registry: Dong-A Pharmaceutical
- Effect of a Liquid Toothpaste on Periodontal DiseaseCompletedNCT03117153Not applicable
Sponsor listed in the registry: Dong-A Pharmaceutical
- Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult VolunteersStatus unknownNCT02058472Phase 1
- Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral AdministrationStatus unknownNCT01929213Phase 1
- Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male SubjectsCompletedNCT01941199Phase 1
- Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and DapoxetineStatus unknownNCT01928563Phase 1
- Clinical Trial to Evaluate the Efficacy and Safety of DA-8031 in Male Patients With Premature EjaculationStatus unknownNCT01798667Phase 2
- Clinical Trial of Motilitone on Gastric Motor Function in Healthy VolunteersCompletedNCT01719575Phase 4
- Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic HyperplasiaCompletedNCT01922375Phase 4
- Study of SI000413 in Knee Osteoarthritis PatientsStatus unknownNCT01525758Phase 2
- Clinical Trial Comparing the Efficacy and Safety of DA-3803 and OvidrelCompletedNCT01718119Phase 3
- Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male SubjectsCompletedNCT01156779Phase 1
- A Study to Evaluate the Safety of DA-3030 and to Explore the Efficacy for Diabetic Neuropathic PainCompletedNCT01820715Phase 1
- Safety Study of Once-a-Day Dosing of Udenafil to Treat Erectile DysfunctionCompletedNCT01901640Phase 3
- A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803CompletedNCT01851512Phase 1
- A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034Status unknownNCT01813812Phase 3
- A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male VolunteersCompletedNCT01776047Phase 1
- Efficacy and Safety Study of Udenafil to Treat Erectile DysfunctionCompletedNCT01774864Phase 3
- A Pharmacokinetic Study of Udenafil in Adult Subjects With or Without Impaired Hepatic FunctionCompletedNCT00956306Phase 1
- A Study to Characterize the Pharmacokinetics of DA-8031 in Healthy Male SubjectsCompletedNCT01104948Phase 1
- A Study to Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male SubjectsStatus unknownNCT00961025Phase 1